However, whether GLP-1RA treatment influences circulating sCD36 levels in patients with DKD, and how these changes correlate with renal function indicators such as urinary albumin-to-creatinine ratio (UACR), remains poorly understood. This evidence concerns the gene ALB and diabetic kidney disease.